6. Below is shown a novel stent on which a drug-loaded hydroxyapatite coating wi

Question

6. Below is shown a novel stent on which a drug-loaded hydroxyapatite coating with porous structure was made. Please give some comments to the people who want to buy this technology? (15) MIV Polymer-Free DES Combine A Novel NanoPorous HAp Surface Modification With Lipid-Based Drug Delivery Technologies And Release Drug In Capsules PCR08 The HAp lattice provides the structural rigidlity required to allow the use of lipid- based drug delivery technologies which deliver the drug in capsules Drug mitures are loaded into the hydroxyapatite pores to form an ultra fexible drug delivery coating that is 0.6 microns thin and extremely durable

Explanation / Answer

It is successful in diminishing LL and neointimal hyperplasia at 4 and 9 months, with no confirmation recently make up for lost time by quantitative coronary angiography or intravascular ultrasound. Tough polymers in original medication eluting stents (DES) have been connected to nearby provocative response prompting a positive vessel rebuilding, late fragmented stent relation, and at times, stent thrombosis. The expulsion of the polymer from the DES framework could expand the security profile of this novel innovation.

Related Questions

Navigate

• Browse (All)
• Browse 6
• Subjects

---

---

Integrity-first tutoring: explanations and feedback only — we do not complete graded work. Learn more.